Soluble suppression of tumorigenicity 2 (sST2), but not galactin-3, adds to prognostication in patients with systemic AL amyloidosis independent of NT-proBNP and troponin T
Dispenzieri, Angela, Gertz, Morie A., Saenger, Amy, Kumar, Shaji K., Lacy, Martha Q., Buadi, Francis K., Dingli, David, Leung, Nelson, Zeldenrust, Steven, Hayman, Suzanne R., Kapoor, Prashant, Grogan,Volume:
90
Language:
english
Journal:
American Journal of Hematology
DOI:
10.1002/ajh.24001
Date:
June, 2015
File:
PDF, 452 KB
english, 2015